MCM7 and prostate cancer: Analysis of a TCGA cohort revealed that the expression levels of NAT10 and Ki67, CDC6, and MCM7 were generally involved in the proliferation of prostate cancer cells and their differentiation (Gleason pattern), metastasis and clinical outcome, indicating their possible roles in promoting the progression of prostate cancers.